PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer
PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer
Active, not recruiting · NCT06133517 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer | Urothelial Bladder Carcinoma | Active, not recruiting | Phase 2 | 2026-10-07 | NCT06133517 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Apices Soluciones S.L. | 14 |
| Fundación para el Progreso de la Oncología en Cantabria | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clinico Universitario de Valladolid | Valladolid | Spain | 1 |
| Hospital Clínico San Carlos | Madrid | Spain | 4 |
| Hospital Duran i Reynals (ICO L´Hospitalet) | L'Hospitalet de Llobregat | Spain | 1 |
| Hospital Universitario de Navarra | Pamplona | Spain | 4 |
| Hospital Universitario Marqués de Valdecilla | Santander | Spain | 9 |
| Hospital Virgen de la Salud | Toledo | Spain | 1 |